Sponsored Content
Analyzation of a diverse set of PROTAC (Proteolysis Targeting Chimeras – a class of TPDs) structures and their calculated properties, identifying key structure-property trends that contribute to low oral bioavailability.
Bend BioScience
Advertisement
Articles by Bend BioScience
Sponsored Content
A case study in converting a solution formulation of a protein into an oral solid dosage form utilizing a fluid bed granulation process and some of the complexities involved.
Webcasts
Webinar Date/Time: Fri, Dec 13, 2024 11:00 AM EST
Advertisement
Latest Updated Articles
Challenges and Triumphs in Next-Generation Biotherapeutic DevelopmentNovember 20th 2024
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing
2
Meeting Tomorrow's Market Requirements: Vetter's Perspective on the Future of Fill & Finish
3
Why Drug Shortages Average 5+ Years: PharmTech Explained
4
ADCs, Degraders, Agonists: 4 Deals CMC Teams Should Track
5